Company Management

ORCA Therapeutics

Biotechnology Nijmegen, Gelderland, Nl 6 employees

Employees: 6
Contacts: 3
Emails: 3

orca-therapeutics.com LinkedIn Crunchbase

ORCA Therapeutics Overview

Headquarters: Nijmegen, Gelderland, Nl
Phone Number: Available in AeroLeads
Website: orca-therapeutics.com
Industry: Biotechnology
Employees: 6
Founded: 2005
Funding: 1.7M

Keywords

Biotechnology Pharma Science Cancer Treatment Innovation

About ORCA Therapeutics

ORCA Therapeutics B.V. is a privately-funded biopharmaceutical company designing and developing new oncolytic immunotherapies for treatment of cancer using Oncolytic Replication Competent Agents (ORCA). At ORCA we are passionate about using viruses to cure cancer patients. Our proprietary technologies allow us to engineer powerful oncolytic adenoviruses that selectively kill cancer cells and induce an antitumor immune response. ORCA’s lead compound ORCA-010 is being developed for treatment naive patients with prostate cancer. For more information, please visit http://www.orca-therapeutics.com

ORCA Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

ORCA Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Victor Van Beusechem	Professor of Applied Molecular Oncology at Amsterdam University Medical Centers	Amsterdam, North Holland, Netherlands	Email
Reza Nadafi	Scientist Immunology - Translational Cancer Immunotherapist	Netherlands	Email
Winald Gerritsen	Senior Medical Advisor	Arnhem-nijmegen Region, Netherlands	Email
Wenliang Dong	Chief Executive Officer at Orca Therapeutics		View